Gene name - smoothened
Cytological map position - 21B7-C1
Function - hedgehog receptor
Keywords - segment polarity gene
Symbol - smo
Genetic map position - 2-0.4
Classification - seven-pass transmembrane protein
Cellular location - surface
|Recent literature||Marada, S., Navarro, G., Truong, A., Stewart, D. P., Arensdorf, A. M., Nachtergaele, S., Angelats, E., Opferman, J. T., Rohatgi, R., McCormick, P. J. and Ogden, S. K. (2015). Functional divergence in the role of N-linked glycosylation in Smoothened signaling. PLoS Genet 11: e1005473. PubMed ID: 26291458
The G protein-coupled receptor (GPCR) Smoothened (Smo) is the requisite signal transducer of the evolutionarily conserved Hedgehog (Hh) pathway. Although aspects of Smo signaling are conserved from Drosophila to vertebrates, significant differences have evolved. These include changes in its active sub-cellular localization, and the ability of vertebrate Smo to induce distinct G protein-dependent and independent signals in response to ligand. Whereas the canonical Smo signal to Gli transcriptional effectors occurs in a G protein-independent manner, its non-canonical signal employs Galphai. Whether vertebrate Smo can selectively bias its signal between these routes is not yet known. N-linked glycosylation is a post-translational modification that can influence GPCR trafficking, ligand responsiveness and signal output. Smo proteins in Drosophila and vertebrate systems harbor N-linked glycans, but their role in Smo signaling has not been established. This study presents a comprehensive analysis of Drosophila and murine Smo glycosylation that supports a functional divergence in the contribution of N-linked glycans to signaling. Of the seven predicted glycan acceptor sites in Drosophila Smo, one is essential. Loss of N-glycosylation at this site disrupted Smo trafficking and attenuated its signaling capability. In stark contrast, all four predicted N-glycosylation sites on murine Smo were dispensable for proper trafficking, agonist binding and canonical signal induction. However, the under-glycosylated protein was compromised in its ability to induce a non-canonical signal through Galphai, providing for the first time evidence that Smo can bias its signal and that a post-translational modification can impact this process. As such, a profound shift is postulated in N-glycan function from affecting Smo ER exit in flies to influencing its signal output in mice.
|Li, S., Li, S., Han, Y., Tong, C., Wang, B., Chen, Y. and Jiang, J. (2016). Regulation of Smoothened phosphorylation and high-level Hedgehog signaling activity by a plasma membrane associated kinase. PLoS Biol 14: e1002481. PubMed ID: 27280464
Hedgehog (Hh) signaling controls embryonic development and adult tissue homeostasis through the G protein coupled receptor (GPCR)-family protein Smoothened (Smo). Upon stimulation, Smo accumulates on the cell surface in Drosophila or primary cilia in vertebrates, which is thought to be essential for its activation and function, but the underlying mechanisms remain poorly understood. This study shows that Hh stimulates the binding of Smo to a plasma membrane-associated kinase Gilgamesh (Gish)/CK1γ and that Gish fine-tunes Hh pathway activity by phosphorylating a Ser/Thr cluster (CL-II) in the juxtamembrane region of Smo carboxyl-terminal intracellular tail (C-tail). It was found that CL-II phosphorylation is promoted by protein kinase A (PKA)-mediated phosphorylation of Smo C-tail and depends on cell surface localization of both Gish and Smo. Consistent with CL-II being critical for high-threshold Hh target gene expression, its phosphorylation appears to require higher levels of Hh or longer exposure to the same level of Hh than PKA-site phosphorylation on Smo. Furthermore, vertebrate CK1γ localizes at the primary cilium to promote Smo phosphorylation and Sonic hedgehog (Shh) pathway activation. These data reveal a conserved mechanism whereby Hh induces a change in Smo subcellular localization to promote its association with and activation by a plasma membrane localized kinase, and provide new insight into how Hh morphogen progressively activates Smo.
|Giordani, G., Barraco, M., Giangrande, A., Martinelli, G., Guadagnuolo, V., Simonetti, G., Perini, G. and Bernardoni, R. (2016). The human Smoothened inhibitor PF-04449913 induces exit from quiescence and loss of multipotent Drosophila hematopoietic progenitor cells. Oncotarget [Epub ahead of print]. PubMed ID: 27486815
The efficient treatment of hematological malignancies as Acute Myeloid Leukemia, myelofibrosis and Chronic Myeloid Leukemia, requires the elimination of cancer-initiating cells. In mammals, inhibition of Smoothened, the key mediator of the Hedgehog signaling pathway, reduces Chronic Myeloid Leukemia progression and propagation. These findings make Smo a candidate target to inhibit maintenance of leukemia-initiating cells. In Drosophila the same pathway maintains the hematopoietic precursor cells of the lymph gland, the hematopoietic organ that develops in the larva. This study investigated in Drosophila the mode of action of PF-04449913, a small-molecule inhibitor of the human Smo protein. Drosophila larvae fed with PF-04449913 showed traits of altered hematopoietic homeostasis. These include the development of melanotic nodules, increase of circulating hemocytes, the size increase of the lymph gland and accelerated differentiation of blood cells likely due to the exit of multi-potent precursors from quiescence. Importantly, the Smo inhibition can lead to the complete loss of hematopoietic precursors. It is concluded that PF-04449913 inhibits Drosophila Smo blocking the Hh signaling pathway and causing the loss of hematopoietic precursor cells. Interestingly, this is the effect expected in patients treated with PF-04449913: number decrease of cancer initiating cells in the bone marrow to reduce the risk of leukemia relapse. Altogether these results indicate that Drosophila comprises a model system for the in vivo study of molecules that target evolutionary conserved pathways implicated in human hematological malignancies.
|Jiang, K., Liu, Y., Fan, J., Zhang, J., Li, X. A., Evers, B. M., Zhu, H. and Jia, J. (2016). PI(4)P promotes phosphorylation and conformational change of Smoothened through interaction with its C-terminal tail. PLoS Biol 14: e1002375. PubMed ID: 26863604
In Hedgehog (Hh) signaling, binding of Hh to the Patched-Interference Hh (Ptc-Ihog) receptor complex relieves Ptc inhibition on Smoothened (Smo). A longstanding question is how Ptc inhibits Smo and how such inhibition is relieved by Hh stimulation. This study found that Hh elevates production of phosphatidylinositol 4-phosphate (PI(4)P). Increased levels of PI(4)P promote, whereas decreased levels of PI(4)P inhibit, Hh signaling activity. It was further found that PI(4)P directly binds Smo through an arginine motif, which then triggers Smo phosphorylation and activation. Moreover, the pleckstrin homology (PH) domain of G protein-coupled receptor kinase 2 (Gprk2) was identified as an essential component for enriching PI(4)P and facilitating Smo activation. PI(4)P also binds mouse Smo (mSmo) and promotes its phosphorylation and ciliary accumulation. Finally, Hh treatment increases the interaction between Smo and PI(4)P but decreases the interaction between Ptc and PI(4)P, indicating that, in addition to promoting PI(4)P production, Hh regulates the pool of PI(4)P associated with Ptc and Smo.
|Byrne, E. F., Sircar, R., Miller, P. S., Hedger, G., Luchetti, G., Nachtergaele, S., Tully, M. D., Mydock-McGrane, L., Covey, D. F., Rambo, R. P., Sansom, M. S., Newstead, S., Rohatgi, R. and Siebold, C. (2016). Structural basis of Smoothened regulation by its extracellular domains. Nature 535: 517-522. PubMed ID: 27437577
Developmental signals of the Hedgehog (Hh) and Wnt families are transduced across the membrane by Frizzled-class G-protein-coupled receptors (GPCRs; see Drosophila Frizzled) composed of both a heptahelical transmembrane domain (TMD) and an extracellular cysteine-rich domain (CRD). How the large extracellular domains of GPCRs regulate signalling by the TMD is unknown. This study presents crystal structures of the Hh signal transducer and oncoprotein Smoothened, a GPCR that contains two distinct ligand-binding sites: one in its TMD and one in the CRD. The CRD is stacked atop the TMD, separated by an intervening wedge-like linker domain. Structure-guided mutations show that the interface between the CRD, linker domain and TMD stabilizes the inactive state of Smoothened. Unexpectedly, a cholesterol molecule was found bound to Smoothened in the CRD binding site. Mutations predicted to prevent cholesterol binding impair the ability of Smoothened to transmit native Hh signals. Binding of a clinically used antagonist, vismodegib, to the TMD induces a conformational change that is propagated to the CRD, resulting in loss of cholesterol from the CRD–linker domain–TMD interface. These results clarify the structural mechanism by which the activity of a GPCR is controlled by ligand-regulated interactions between its extracellular and transmembrane domains.
Zhang, J., Liu, Y., Jiang, K. and Jia, J.
(2017). SUMO regulates the
activity of Smoothened and Costal-2 in Drosophila Hedgehog
signaling. Sci Rep 7: 42749. PubMed ID: 28195188
In Hedgehog (Hh) signaling, the GPCR-family protein Smoothened (Smo) acts as a signal transducer that is regulated by phosphorylation and ubiquitination, which ultimately change the cell surface accumulation of Smo. However, it is not clear whether Smo is regulated by other post-translational modifications, such as sumoylation. This study demonstrates that knockdown of the small ubiquitin-related modifier (SUMO) pathway components Ubc9 (a SUMO-conjugating enzyme E2), PIAS (a SUMO-protein ligase E3), and Smt3 (the SUMO isoform in Drosophila) by RNAi prevents Smo accumulation and alters Smo activity in the wing. Hh-induced-sumoylation stabilizes Smo, whereas desumoylation by Ulp1 destabilizes Smo in a phosphorylation independent manner. Mechanistically, excessive Krz, the Drosophila β-arrestin 2, inhibits Smo sumoylation and prevents Smo accumulation through Krz regulatory domain. Krz likely facilitates the interaction between Smo and Ulp1 because knockdown of Krz by RNAi attenuates Smo-Ulp1 interaction. Finally, Cos2 is also sumoylated, which counteracts its inhibitory role on Smo accumulation in the wing. Taken together, these results uncover a novel mechanism for Smo activation by sumoylation that is regulated by Hh and Smo interacting proteins.
|Sanial, M., Becam, I., Hofmann, L., Behague, J., Arguelles, C., Gourhand, V., Bruzzone, L., Holmgren, R. A. and Plessis, A. (2017). Dose dependent transduction of Hedgehog relies on phosphorylation-based feedback between the GPCR Smoothened and the kinase Fused. Development 144(10):1841-1850. PubMed ID: 28360132
Smoothened (SMO) is a GPCR-related protein required for the transduction of Hedgehog (HH). The HH gradient leads to graded phosphorylation of SMO, mainly by the PKA and CKI kinases. How thresholds in HH morphogen regulate SMO to promote switch-like transcriptional responses is a central unsolved issue. Using the wing imaginal disc model in Drosophila, this study identified novel SMO phosphosites that enhance the effects of the PKA/CKI kinases on SMO accumulation, its localization at the plasma membrane and its activity. Surprisingly, phosphorylation at these sites is induced by the kinase Fused (FU), a known downstream effector of SMO. In turn activation of SMO induces FU to act on its downstream targets. Together these data provide evidence for a SMO/FU positive regulatory loop nested within a multi-kinase phosphorylation cascade. It is proposed that this complex interplay amplifies signaling above a threshold that allows high HH signaling.
|Albert, E. A. and Bokel, C. (2017). A cell based, high throughput assay for quantitative analysis of Hedgehog pathway activation using a Smoothened activation sensor. Sci Rep 7(1): 14341. PubMed ID: 29085027
The Hedgehog (Hh) signalling cascade plays an important role in development and disease. In the absence of Hh ligand, activity of the key signal transducer Smoothened (Smo) is downregulated by the Hh receptor Patched (Ptc). However, the mechanisms underlying this inhibition, and especially its release upon ligand stimulation, are still poorly understood, in part because tools for following Smo activation at the subcellular level were long lacking. To address this deficit this study has developed a high throughput cell culture assay based on a fluorescent sensor for Drosophila Smo activation. A small molecule inhibitor library was screened, and increased Smo sensor fluorescence was observed with compounds aimed at two major target groups, the MAPK signalling cascade and Polo and Aurora kinases. Biochemical validation for selected inhibitors (dobrafenib, tak-733, volasertib) confirmed the screen results and revealed differences in the mode of Smo activation. Furthermore, monitoring Smo activation at the single cell level indicated that individual cells exhibit different threshold responses to Hh stimulation, which may be mechanistically relevant for the formation of graded Hh responses. Together, these results thus provide proof of principle that this assay may become a valuable tool for dissecting the cell biological basis of Hh pathway activation.
|Jiang, K., Liu, Y., Zhang, J. and Jia, J. (2017). An intracellular activation of Smoothened independent of Hedgehog stimulation in Drosophila. J Cell Sci. PubMed ID: 29142103
Smoothened (Smo), a GPCR family protein, plays a critical role in the reception and transduction of Hedgehog (Hh) signal. Smo is phosphorylated and activated on the cell surface, however, it is unknown whether Smo can be intracellularly activated. This study demonstrates that inactivation of the ESCRT-III causes dramatic accumulation of Smo, and subsequent activation of Hh signaling. In contrast, inactivation of ESCRTs 0-II induces mild Smo accumulation. Evidence is porvided that Kurtz (Krz), the Drosophila beta-arrestin2, acts in parallel with the ESCRTs 0-II pathway to sort Smo to the multivesicular bodies and lysosome-mediated degradation. Additionally, upon inactivation of ESCRT-III, all active and inactive forms of Smo are accumulated. Endogenous Smo accumulated by ESCRT-III inactivation is highly activated, which is induced by phosphorylation but not sumoylation. Together, these findings demonstrate a model for intracellular activation of Smo, raising the possibility for tissue overgrowth caused by an excessive amount, rather than mutation of Smo.
|Li, S., Li, S., Wang, B. and Jiang, J. (2018). Hedgehog reciprocally controls trafficking of Smo and Ptc through the Smurf family of E3 ubiquitin ligases. Sci Signal 11(516). PubMed ID: 29438012
Hedgehog (Hh) induces signaling by promoting the reciprocal trafficking of its receptor Patched (Ptc) and the signal transducer Smoothened (Smo), which is inhibited by Ptc, at the cell surface. Smurf family E3 ubiquitin ligases were identified as essential for Smo ubiquitylation and cell surface clearance, and Smurf family members were found to mediate the reciprocal trafficking of Ptc and Smo in Drosophila melanogaster G protein-coupled receptor kinase 2 (Gprk2)-mediated phosphorylation of Smurf promoted Smo ubiquitylation by increasing the recruitment of Smurf to Smo, whereas protein kinase A (PKA)-mediated phosphorylation of Smo caused Smurf to dissociate from Smo, thereby inhibiting Smo ubiquitylation. Smo and Ptc competed for the same pool of Smurf family E3 ubiquitin ligases, and Hh promoted Ptc ubiquitylation and degradation by disrupting the association of Smurf family E3 ubiquitin ligases with Smo and stimulating their binding to Ptc. This study identifies the E3 ubiquitin ligases that target Smo and provides insight into how Hh regulates the reciprocal trafficking of its receptor and signal transducer.
|Li, S., Cho, Y. S., Wang, B., Li, S. and Jiang, J. (2018). Regulation of Smoothened ubiquitination and cell surface expression by a Cul4-DDB1-Gbeta E3 ubiquitin ligase complex. J Cell Sci. PubMed ID: 29930086
Hedgehog (Hh) transduces signal by promoting cell surface accumulation and activation of the G protein coupled receptor (GPCR)-family protein Smoothened (Smo) in Drosophila, but the molecular mechanism underlying the regulation of Smo trafficking has remained poorly understood. This study identified a Cul4-DDB1 E3 ubiquitin ligase complex as essential for Smo ubiquitination and cell surface clearance. The C-terminal intracellular domain of Smo was found to recruit Cul4-DDB1 through the beta subunit of trimeric G protein (Gbeta), and that Cul4-DDB1-Gbeta promotes the ubiquitination of both Smo and its binding partner G-protein-coupled-receptor-kinase 2 (Gprk2) and induces the internalization and degradation of Smo. Hh dissociates Cul4-DDB1 from Smo by recruiting the catalytic subunit of protein kinase A (PKA) to phosphorylate DDB1, which disrupts its interaction with Gbeta. Inactivation of the Cul4-DDB1 complex resulted in elevated Smo cell surface expression whereas excessive Cul4-DDB1 blocked Smo accumulation and attenuated Hh pathway activation. Taken together, this study identifies an E3 ubiquitin ligase complex targeting Smo for ubiquitination and provides new insight into how Hh signaling regulates Smo trafficking and cell surface expression.
Smoothened protein is thought to be a component of the Hedgehog receptor (Alcedo, 1996). The pathway for Hedgehog regulated induction of wingless is complex, involving both Smoothened and another membrane protein (Patched) thought to be the direct receptor for Hedgehog. Hh action alleviates the negative regulation of Hh target genes and they become transcriptionally active.
Surprisingly, a vertebrate homolog of Smoothened (vSMO), shows no direct interaction with mouse Sonic hedgehog (SHH), and Sonic hedgehog binds mPtc, a murine homolog of Patched, with high affinity. For example, epitope-tagged SHH as well as IgG-Sonic HH, both hybrid proteins containing the N terminal region of Sonic HH attached covalently to second proteins, bind to cells expressing mPTC, and no change in the affinity between SHH and PTC is observed in the presence of vSMO. mPTC can be co-immunoprecipitated with epitope-tagged SHH. Nevertheless, the three proteins can form a physical complex. In cells coexpressing mPTC and vSMO, vSMO can be co-immunoprecipitated with antibody against epitope-tagged mPTC. Thus in the end, it appears that Patched, and not SMO is the protein that directly interacts with SHH (Stone, 1996).
Confirming evidence comes from experiments in which chicken ptc was expressed in Xenopus oocytes. Binding of labelled SHH is detected in ptc transduced oocytes but not in untransduced controls. Co-immunoprecipitation experiments reveal that when transduced cells are treated with SHH and extracted, SHH can be detected in immuno-preciptates carried out with antibody against epitope tagged PTC (Marigo, 1996).
Chen and Struhl (1996) argue that PTC is positioned upstream of SMO in the HH signal transduction pathway, either as a factor that regulates SMO-transducting activity in response to HH or as a factor that facilitates the direct modulation of SMO activity by HH (Chen, 1996).
It seems likely that Patched and Smoothened function as receptor and signal transducing proteins respectively. Smoothened and Patched associate with each other on the membrane. In the absence of ligand, PTC inhibits signaling of Smoothened, while in the presence of ligand, PTC inhibition of SMO signaling is released and SMO signaling is activated.
Apparently, Ptc and Smo are not significantly associated within Hh-responsive cells. Furthermore, free Ptc (unbound by Hh) has been shown to act sub-stoichiometrically to suppress Smo activity and thus is critical in specifying the level of pathway activity. Patched is a twelve-transmembrane protein with homology to bacterial proton-driven transmembrane molecular transporters; the function of Ptc is impaired by alterations of residues that are conserved in and required for function of these bacterial transporters. These results suggest that the Ptc tumor suppressor functions normally as a transmembrane molecular transporter, which acts indirectly to inhibit Smo activity, possibly through changes in distribution or concentration of a small molecule (Taipale, 2002).
Mutation of smoothened has been used to unravel the complex regulation of segmental boundary function in Drosophila. Segmental primordium is subdivided into two cell populations (the anterior (A) and posterior (P) compartments) by the selective activity of the transcription factor Engrailed (En) in P cells. Under En control, P cells secrete, but cannot respond to, the signaling protein Hedgehog (Hh). In contrast, and by default, A cells are programmed to respond to Hh by expressing other signaling molecules, such as Decapentaplegic (Dpp) and Wingless (Wg), which organize growth and patterning in both compartments. Cells of the A and P compartments do not intermix, apparently as a consequence of their having distinct cell affinities that cause them to maximize contact with cells of the same compartment, while minimizing contact with cells from the other compartment. This failure to mix has previously been ascribed to an autonomous and direct role for En in specifying a P cell affinity (as opposed to an A cell affinity). However, an alternative hypothesis is that Hh secreted by P cells induces A cells to acquire a distinct cell affinity, ensuring that a stable 'affinity boundary' forms wherever P and A cells meet. To distinguish between these two hypotheses, a mutation was used in the gene smoothened to block the ability of A-compartment cells to receive and transduce Hh. If distinct A and P cell affinities are specified autonomously by the expression state of En expression, then anterior cells should retain their A-compartment affinity and sort out from P cells, even if their ability to respond to Hh is blocked by the loss of smo activity. Conversely, if it is the Hh signal that normally induces a local affinity difference between A and P cells, then a block in the Hh signal transduction could cause the affected A cells to sort out from wild-type A cells that do receive the Hh signal, and to intermix instead with P cells on the other side of the compartment boundary. The affinity boundary that segregates A and P cells into adjacent but immiscible cell populations is to a large extent a consequence of local Hh signaling, rather than a reflection of an intrinsic affinity difference between A and P cells (Rodriguez, 1997).
In the Drosophila wing, Hedgehog is made by cells of the posterior compartment and acts as a morphogen to pattern cells of the anterior compartment. High Hedgehog levels instruct L3/4 intervein fate, whereas lower levels instruct L3 vein fate. Transcriptional responses to Hedgehog are mediated by the balance between repressor and activator forms of Cubitus interruptus, CiR and CiA. Hedgehog regulates this balance through its receptor, Patched, which acts through Smoothened and thence a regulatory complex that includes Fused, Costal, Suppressor of Fused and Cubitus interruptus. It is not known how the Hedgehog signal is relayed from Smoothened to the regulatory complex nor how responses to different levels of Hedgehog are implemented. Chimeric and deleted forms of Smoothened were used to explore the signaling functions of Smoothened. A Frizzled/Smoothened chimera containing the Smo cytoplasmic tail (FFS) can induce the full spectrum of Hedgehog responses but is regulated by Wingless rather than Hedgehog. Smoothened whose cytoplasmic tail is replaced with that of Frizzled (SSF) mimics fused mutants, interfering with high Hedgehog responses but with no effect on low Hedgehog responses. The cytoplasmic tail of Smoothened with no transmembrane or extracellular domains (SmoC) interferes with high Hedgehog responses and allows endogenous Smoothened to constitutively initiate low responses. SmoC mimics costal mutants. Genetic interactions suggest that SSF interferes with high signaling by titrating out Smoothened, whereas SmoC drives constitutive low signaling by titrating out Costal. These data suggest that low and high signaling (1) are qualitatively different, (2) are mediated by distinct configurations of the regulatory complex and (3) are initiated by distinct activities of Smoothened. A model is presented where low signaling is initiated when a Costal inhibitory site on the Smoothened cytoplasmic tail shifts the regulatory complex to its low state. High signaling is initiated when cooperating Smoothened cytoplasmic tails activate Costal and Fused, driving the regulatory complex to its high state. Thus, two activities of Smoothened translate different levels of Hedgehog into distinct intracellular responses (Hooper, 2003).
Analyses of the activities of truncated and chimeric forms of Smo in a variety of genetic backgrounds yielded four principal observations. (1)The FFS chimera activates the full spectrum of Hh responses, but is regulated by Wg rather than Hh. From this, it is concluded that the Smo cytoplasmic tail initiates all intracellular responses to Hh, while the remainder of Smo regulates activity of the tail. (2) The SSF chimera interferes with high signaling but has no effect on low signaling. SSF mimics Class II fu mutants and is suppressed by increasing smo+ but not fu+ or cos+. From this, it is concluded that high Hh instructs Smo to activate Fu by a mechanism that is likely to involve dimeric/oligomeric Smo. (3) The cytoplasmic tail of Smo (SmoC) derepresses endogenous Smo activity in the absence of Hh and represses endogenous Smo activity in the presence of high Hh. That is, SmoC drives cells to the low response regardless of Hh levels. This mimics cos mutants and is suppressed by 50% increase in cos+. From this, it is concluded that low Hh instructs Smo to inactivate Cos, by a mechanism that may involve stoichiometric interaction between Cos and the Smo cytoplasmic tail. (4) Chimeras where the extracellular CRD and TM domains are mismatched fail to exhibit any activity. From this, it is concluded that these two domains act as an integrated functional unit. This leads to a model for signaling where Fz or Smo can adopt three distinct states, regulating two distinct activities and translating different levels of ligand into distinct responses. Many physical models are consistent with these genetic analyses (Hooper, 2003).
Two mutant forms of Smo have been identified that regulate downstream signaling through different activities. These mutant forms of Smo mimic phenotypes of mutants in other components of the Hh pathway, as well as normal responses to different levels of Hh. These data suggest a model where Smo can adopt three distinct states that instruct three distinct states of the Ci regulatory complex. The model further suggests that Smo regulates Ci through direct interactions between Fu, Cos and the cytoplasmic tail of Smo. This is consistent with the failure of numerous genetic screens to identify additional signaling intermediates, and with the exquisite sensitivity of low signaling to Cos dosage (Hooper, 2003).
The model proposes that Smo can adopt three states, a decision normally dictated by Hh, via Ptc. The Ci regulatory complex, which includes full-length Ci, Cos and Fu, likewise can adopt three states. (1) In the absence of Hh Smo is OFF. Its cytoplasmic aspect is unavailable for signaling. The Cos/Fu/Ci regulatory complex is anchored to microtubules and promotes efficient processing of Ci155 to CiR. (2) Low levels of Hh expose Cos inhibitory sites in the cytoplasmic tail of Smo. Cos interaction with these sites drives the Ci regulatory complex into the low state, which recruits Su(fu) and makes little CiR or CiA. (3) High levels of Hh drive a major change in Smo, possibly dimerization. This allows the cytoplasmic tails of Smo to cooperatively activate Fu and Cos. Fu* and Cos* (* indicates the activated state) then cooperate to inactivate Su(fu), to block CiR production, and to produce CiA at the expense of Ci155 (Hooper, 2003).
The OFF state is normally found deep in the anterior compartment where cells express no Hh target genes (except basal levels of Ptc). In this state, the Ci regulatory complex consists of Fu/Cos/Ci155. Cos and Fu contribute to efficient processing of Ci155 to the repressor form, CiR, presumably because the complex promotes access of PKA and the processing machinery to Ci155, correlating with microtubule binding of the complex. This state is universal in hh or smo mutants, indicating that intracellular responses to Hh cannot be activated without Smo. Therefore Smo can adopt an OFF state where it exerts no influence on downstream signaling components and the OFF state of the Ci regulatory complex is its default state (Hooper, 2003).
The low state is normally found approximately five to seven cells from the compartment border, where cells are exposed to lower levels of Hh. These cells express Iro, moderate levels of dpp, no Collier and basal levels of Ptc. They accumulate Ci155, indicating that little CiA or CiR is made. Ci155 can enter nuclei but is insufficient to activate high responses. The physical state of the Ci regulatory complex in the low state has not been investigated. Cells take on the low state regardless of Hh levels when Ci is absent or when SmoC is expressed, and are strongly biased towards that state in fu(classII); Su(fu) double mutants. This state normally requires input from Smo, which becomes constitutive in the presence of SmoC. Because SmoC drives only low responses and cannot activate high responses, this identifies a low state of Smo that is distinct from both OFF and high. It is proposed that the low state is normally achieved when Smo inactivates Cos, perhaps by direct binding of Cos to Smo and dissociation of Cos from Ci155. Neither CiR nor CiA is made efficiently, and target gene expression is similar to that of ci null mutants (Hooper, 2003).
The high state is normally found in the two or three cells immediately adjacent to the compartment border where there are high levels of Hh. These cells express En, Collier, high levels of Ptc and moderate levels of Dpp. They make CiA rather than CiR, and Ci155 can enter nuclei. In this state a cytoplasmic Ci regulatory complex consists of phosphorylated Cos, phosphorylated Fu, Ci155 and Su(fu). Dissociation of Ci from the complex may not precede nuclear entry, since Cos, Fu, and Sufu are all detected in nuclei along with Ci155. Sufu favors the low state, whereas Cos and Fu cooperate to allow the high state by repressing Sufu, and also by a process independent of Sufu. This high state is the universal state in ptc mutants and requires input from Smo. As this state is specifically lost in fu mutants, Fu may be a primary target through which Smo activates the high state. SSF specifically interferes with the high state by a mechanism that is most sensitive to dosage of Smo. This suggests SSF interferes with the high activity of Smo itself. It is suggested that dimeric/oligomeric Smo is necessary for the high state, and that Smo:SSF dimers are non-productive. Cooperation between Smo cytoplasmic tails activates Fu and thence Cos. The activities of the resulting Fu* and Cos* are entirely different from their activities in the OFF state, and mediate downstream effects on Sufu and Ci (Hooper, 2003).
The cytoplasmic tail of Smo is sufficient to activate all Hh responses, and its activity is regulated through the extracellular and TM domains. This is exemplified by the FFS chimera, which retains the full range of Smo activities, but is regulated by Wg rather than Hh. The extracellular and transmembrane domains act as an integrated unit to activate the cytoplasmic tail, since all chimeras interrupting this unit fail to activate any Hh responses, despite expression levels and subcellular localization similar to those of active SSF or FFS. As is true of other serpentine receptors, a global rearrangement of the TM helices is likely to expose 'active' (Cos regulatory?) sites on the cytoplasmic face of Smo. The extracellular domain of Smo must stabilize this conformation and Ptc must destabilize it. But how? Ptc may regulate Smo through export of a small molecule, which inhibits Smo when presented at its extracellular face. Hh binding to Ptc stimulates its endocytosis and degradation, leaving Smo behind at the cell surface. Thus, Hh would separate the source of the inhibitor (Ptc) from Smo, allowing Smo to adopt the low state. Transition from low to high might require Smo hyperphosphorylation. The high state, which is likely to involve Smo oligomers, might be favored by cell surface accumulation if aggregation begins at some threshold concentration of low Smo. Alternatively, these biochemical changes may all be unnecessary for either the low or high states of Smo (Hooper, 2003).
There is no suggestion that Ptc has multiple states in response to different levels of Hh. Ptc mutants that fail to derepress signaling, or that constitutively derepress signaling coordinately affect both high (e.g. En) and low (e.g. Iro) responses. Thus, it is suggested that Smo and not Ptc is the first step in which the Hh pathway adopts three distinct states (Hooper, 2003).
Both Hhs and Wnts act as morphogens, with different levels of ligand dictating different intracellular responses. Those intracellular responses are respectively initiated by Smo and Fz. Fz and Smo have a high degree of sequence similarity in their extracellular and transmembrane domains. The similarity must extend to function, since graded levels of Wg acting through the FFS chimera drive low and then high signaling by the Smo cytoplasmic tail. This suggests unanticipated complexity in Fz function, where low levels of Wnts 'low-activate' Fz while higher levels trigger oligomerization-dependent 'high activation'. Fz8 CRD crystallizes as a dimer, suggesting a physical basis for Fz family oligomerization (Hooper, 2003).
There is precedent within the serpentine receptor superfamily for dimerization/oligomerization and for multiple signaling states. ß2-adrenergic receptor (ß2AR), the archetypical serpentine receptor has at least three states. In the absence of ligand, ß2AR is OFF. The agonist-occupied state favors a global conformational change that allows the cytoplasmic loops and tail to activate heterotrimeric G proteins as well as the receptor kinase, GRK2. GRK2 then phosphorylates the cytoplasmic tail of ß2AR. In the phosphorylated state, ß2AR binds ß-arrestin. ß2AR + ß-arrestin1 then assemble novel trafficking and signaling complexes that mediate endocytosis, Src binding and ERK activation. Complementation between two inactive ß2AR mutant forms demonstrates that adjacent molecules can exchange helices to reconstitute a functional receptor; that is, ß2AR can homodimerize. Moreover, a peptide derived from the sixth TM domain simultaneously blocks dimerization and activation. There are substantial parallels between this model of ß2AR signaling and the current model of Smo signaling. Each recruits and activates a kinase when the receptor is stimulated. Each stimulated receptor then becomes a substrate for assembly of a new signaling complex. It is suggested that multiple signaling states could be a general mechanism by which serpentine receptors translate different levels and/or kinetics of ligand exposure into distinct responses (Hooper, 2003 and references therein).
Hedgehog (HH) is a major secreted morphogen involved in development, stem cell maintenance and oncogenesis. In Drosophila wing imaginal discs, Hh produced in the posterior compartment diffuses into the anterior compartment to control target gene transcription via the transcription factor Cubitus interruptus (Ci). The first steps in the reception and transduction of the Hh signal are mediated by its receptor Patched (Ptc) and the seven-transmembrane-domain protein Smoothened (Smo). Ptc and Hh control Smo by regulating its stability, trafficking, and phosphorylation. Smo interacts directly with the Ser-Thr protein kinase Fused (Fu) and the kinesin-related protein Costal2 (Cos2), which interact with each other and with Ci in an intracellular Hedgehog transducing complex. Hh induces Fu targeting to the plasma membrane in a Smo-dependent fashion and, reciprocally, Fu controls Smo stability and phosphorylation. Fu anchorage to the membrane is sufficient to make it a potent Smo-dependent, Ptc-resistant activator of the pathway. These findings reveal a novel positive-feedback loop in Hh transduction and are consistent with a model in which Fu and Smo, by mutually enhancing each other's activities, sustain high levels of signaling and render the pathway robust to Ptc level fluctuations (Claret, 2007).
This work provides new information about (1) the mechanisms by which the activation of Smo is transduced to its cytoplasmic effector Fu, (2) the mechanisms of Fu activation, and (3) a novel positive-feedback loop between Fu and Smo. Evidence is provided that Smo controls the subcellular distribution of two of its physical partners, Fu and Cos2, recruiting them to the plasma membrane in response to Hh. The data also suggest that Fu might link Cos2 to Smo in a vesicle-associated complex in the absence of Hh, whereas Fu and Cos2 might independently bind Smo at the plasma membrane in the presence of Hh. Thus, Hh might not only promote, via Smo, the recruitment of Fu and Cos2 to the plasma membrane; it might also modulate the nature of interactions between these three proteins (Claret, 2007).
Several nonexclusive mechanisms seem to be involved in controlling Fu activity. (1) The forced localization of Fu at the membrane induces strong Smo-dependent activation of the pathway in the wing. This study is the first to report a dominant active form of this type of kinase. (2) This study shows that the presence of a conserved Thr in the activating loop is important for the promotion of full Smo phosphorylation and for the activating effects of GAP-Fu. Thus, because Fu is known to be phosphorylated in response to Hh, the phosphorylation of this loop (by autophosphorylation or by other kinases) might be a key element in Fu regulation. (3) Hh might regulate Fu by controlling its dimerization or its interaction with potential regulatory proteins. Possible Fu dimerization is consistent with (1) the reported interaction between the regulatory domain of Fu and its kinase domain, (2) the recruitment to the plasma membrane of wild-type Fu by the wild-type and mutant forms of GAP-Fu, and (3) the dominant negative effects of Fu mutants with modified kinase domains (Claret, 2007).
Evidence is presented for of a novel, positive-feedback loop in which Smo and Fu enhance each other's activities. Indeed, Smo promotes the relocalization of Fu to the plasma membrane and is required for the activating effects of GAP-Fu, whereas both GAP-Fu and Fu control Smo stability and phosphorylation. Fu kinase activity is required for Smo phosphorylation and for the activating effects of GAP-Fu, but not for its association with Smo. Fu might phosphorylate Smo directly or might act on other substrates, indirectly facilitating Smo phosphorylation, inhibiting phosphatases, or stabilizing phosphorylated Smo. Both Fu activity and its interaction with Smo seem to be required for full hyperphosphorylation of Smo in response to Hh (Claret, 2007).
In the wing imaginal disc, Fu is required principally for responses to the highest levels of Hh present at the anteroposterior border, where Smo is active despite the strong upregulation of ptc. The effects of GAP-Fu and Fu on Smo provide the first clues to a putative mechanism (Fu-dependent phosphorylation and stabilization of Smo), potentially accounting for the resistance of Smo to the high level of Ptc induced by Hh in responding cells (Claret, 2007).
The following model is proposed: (1) The Hh-induced relocalization of Smo to the plasma membrane leads to the recruitment of Fu and Cos2 at this membrane. (2) Fu, in turn, acts on Smo, probably by further enhancing its phosphorylation, to stabilize it further and prevent its inhibition by Ptc. It is not yet possible to determine whether Fu regulates Smo directly or indirectly. The kinesin Cos2 may be also part of this regulatory loop. (3) The stabilized, activated Smo/Fu/Cos2 complex at the plasma membrane then promotes the accumulation and activation of Ci-FL, leading to the activation of Hh target genes, including ptc (Claret, 2007).
SmoδFu, which does not bind Fu, is constitutively active, suggesting that Fu might also act as a negative regulator of Smo in the absence of the Hh signal. Thus, Fu might act as a switch, sensing the level of Hh, inhibiting Smo in the absence of Hh or activating the pathway in response to high levels of Hh. Interestingly, the existence of such regulatory loops might account for the bistability properties of signaling pathways and explain how graded levels of signal might act as morphogens, leading to differential cell responses (Claret, 2007).
In conclusion, Fu was found to be recruited by Smo at the plasma membrane in response to Hh and this recruitment was found to be directly dependent on the physical interaction of Fu with Smo. The expression of a membrane-anchored form of Fu (GAP-Fu) constitutively activates the Hh pathway, indicating that Fu activity might be regulated by its subcellular location. Surprisingly, the activating effects of GAP-Fu require a wild-type dose of endogenous Smo. Evidence is reported that (1) Fu and GAP-Fu induce the phosphorylation of Smo, (2) GAP-Fu recruits Smo to the plasma membrane, (3) GAP-Fu renders Smo resistant to the destabilizing effects of Ptc, and (4) Fu controls the level of accumulation of Smo in the wing imaginal disc. Thus, these data demonstrate that Fu, which is generally considered to be an effector of Smo, can also act on Smo (Claret, 2007).
The Hedgehog (Hh) signaling pathway plays an instructional role during development, and is frequently activated in cancer. Ligand-induced pathway activation requires signaling by the transmembrane protein Smoothened (Smo), a member of the G-protein-coupled receptor (GPCR) superfamily. The extracellular (EC) loops of canonical GPCRs harbor cysteine residues that engage in disulfide bonds, affecting active and inactive signaling states through regulating receptor conformation, dimerization and/or ligand binding. Although a functional importance for cysteines localized to the N-terminal extracellular cysteine-rich domain has been described, a functional role for a set of conserved cysteines in the EC loops of Smo has not yet been established. In this study, each of the conserved EC cysteines were mutated, and tested for effects on Hh signal transduction. Cysteine mutagenesis reveals that previously uncharacterized functional roles exist for Smo EC1 and EC2. In vitro and in vivo evidence is provided that EC1 cysteine mutation induces significant Hh-independent Smo signaling, triggering a level of pathway activation similar to that of a maximal Hh response in Drosophila and mammalian systems. Furthermore, it was shown that a single amino acid change in EC2 attenuates Hh-induced Smo signaling, whereas deletion of the central region of EC2 renders Smo fully active, suggesting that the conformation of EC2 is crucial for regulated Smo activity. Taken together, these findings are consistent with loop cysteines engaging in disulfide bonds that facilitate a Smo conformation that is silent in the absence of Hh, but can transition to a fully active state in response to ligand (Carroll, 2012).
Each EC loop cysteine was individually mutated to alanine. The ability of EC loop C to A mutants to rescue Hh-dependent reporter gene activation was tested following knockdown of endogenous smo. Transfection of smo 5'UTR dsRNA into Clone 8 (Cl8) cells eliminated activation of the ptcδ-136-luciferase (ptc-luciferase) reporter construct. As control, wild-type myc-smo was co-transfected with UTR dsRNA, and rescue was observed of Hh-dependent reporter induction to near wild-type levels. Whereas mutation of EC3 cysteine residues (C513A and C525A) did not alter rescue of reporter gene activity, mutation of conserved cysteine residues in EC1 (C320A), TM3 (C339A) and EC2 (C413A) did. Mutation of these residues triggered increased baseline activity, ranging from ~20% (C413A) to ~100% (C339A) of the control Hh response. Although the EC1 and EC2 substitutions were able to induce ectopic signaling in the absence of Hh, they demonstrated attenuated Hh-induced activity, suggesting that alteration of these residues shifts Smo toward a low- to intermediate-level signaling conformation. Myc-SmoC339A was nearly fully active in both the absence and presence of Hh, suggesting that this mutation triggers a highly active conformation (Carroll, 2012).
A functional role for EC loop cysteines in GPCR regulation has been identified through biochemical and structural studies on the prototypical GPCR rhodopsin, which revealed a TM3-EC2 disulfide bridge to be essential for regulated receptor activity. Accordingly, studies on additional GPCR family members support the presence and importance of this bond. C5a receptor mutagenesis revealed TM3 and EC2 cysteines to be necessary for stabilizing its inactive conformation. Based upon this work, it was suggested that a general theme in GPCR biology is that EC2 is restrained by the TM3-EC2 disulfide bridge to drive a closed conformation. Loss of this bond is hypothesized to trigger a relaxed, open conformation capable of ligand-independent signaling (Massotte, 2005; Carroll, 2012 and references therein).
Mutation of Smo TM3 residue C339 or deletion of the central portion of EC2 induced full reporter gene activation, Fu phosphorylation and Ci stabilization in an Hh-independent manner. Further, expression of C339A in vivo induced Hh gain-of-function phenotypes, indicating a robust level of signaling. Given the similarly high signaling by both C339A and δEC2 Smo mutants, it was hypothesized that the canonical GPCR TM3-EC2 bond exists between TM3 reside C339 and EC2 residue C413 of Smo. Why then, does the C339A Smo mutant induce effects on pathway activity that are distinct from those of C413A? It is speculated that activities induced by loss of this bond may be influenced by behavior of the newly free cysteine, probably through engaging in an inappropriate disulfide bond that alters loop conformation. As such, it is hypothesized that enhanced activity of SmoC339A results from C413 forming a disulfide bridge with an inappropriate cysteine that triggers an active EC2 conformation (Carroll, 2012).
C478 is favored as the inappropriate C413 bond partner because: (1) Mutation of C478 in the wild-type background does not alter Smo signaling, suggesting that it is not engaged in an essential disulfide bridge; (2) mutation of C478 in the C339A background converts C339A to an activity level similar to that of C413A; (3) C339 and C478 are approximately equidistant from C413; (4) C413 binding to C478 would probably alter EC2 conformation, potentially mimicking the active state. As such, reversion of C339A/C413A back to a wild-type level of activity is explained by loss of this new, inappropriate bond. These results underscore the importance of EC2 in regulating Smo signaling, suggesting that its conformation is crucial for maintaining Smo in an inactive conformation in the absence of Hh (Carroll, 2012).
In contrast to the high-level activity of C339A and δEC2 Smo mutants, the EC2 mutant C413A facilitated only partial rescue of reporter gene activity in the smo knockdown background, and modest effects on Ci when expressed in a wild-type background in vitro. Accordingly, smo4D1, a C to S mutation of C413, was previously classified as a weak loss of function allele. When the UAS-smoC413A transgene was expressed in vivo, it triggered only modest phenotypes in the wing, and did not affect cell fate in the embryonic ectoderm. The decreased activity of SmoC413A compared with that observed following mutation of its suspected bond partner C339 might be explained by the predicted localization of C339 to the amino-terminus of TM3. This inflexible region may prevent C339 from scavenging a new disulfide bond partner following C413A mutation, thereby preventing an activating conformational shift. However, mutation of C413 does have a functional consequence. Given its inability to fully rescue smo knockdown in vitro or to induce Hh phenotypes in vivo, it is hypothesized that C413A mutation triggers an EC2 conformation that is incapable of becoming fully activated by Hh. This, taken together with the activating effects of δEC2 mutation, highlights the importance of EC2 in regulating the activation state of Smo (Carroll, 2012).
Based upon the phenotypes of SmoC320A it is proposed that EC1 residue C320 is engaged in an additional disulfide bond that assists in stabilizing the inactive conformation of Smo. This conclusion is based upon the ability of C320A to induce moderate pathway activity in vitro and to induce Hh gain-of-function wing phenotypes when expressed in vivo. The presence of two disulfide bonds, one involving C320 and one involving C339, is further supported by the additive effect of the C320A/C339A double mutant, which demonstrated significantly higher ligand-independent signaling than either single mutant. Further, the C320A/C339A/C413A triple mutant triggered a complete loss of function, potentially due to an altered conformation resulting from loss of multiple stabilizing disulfide bonds (Carroll, 2012).
Despite its higher baseline activity, Smo C320A was unable to fully rescue Hh-induced reporter activity in the smo knockdown background. This suggests that, similar to SmoC413A, SmoC320A is unable to transition to a fully active state. As such, higher-level reporter gene induction and wing phenotypes triggered by C320A in a wild-type background probably result from SmoC320A engaging endogenous Smo. Taken together, these results support that, like EC2, EC1 plays an important role in regulating Smo, probably through a conformation dependent upon a disulfide bond involving C320. Although this study does not reveal a bond partner for C320, it is hypothesized that it may interact with one of the numerous cysteines in the amino-terminal cysteine-rich domain (CRD), as the CRD has been proposed to contribute to both active and inactive states of Smo (Aanstad, 2009; Carroll, 2012 and references therein).
mRNA length - 4005 bases
Exons - 6
Bases in 3' UTR - 654
SMO is an integral membrane protein with seven membrane spanning alpha helices and a long hydrophilic C-terminal tail. An additional hydrophobic segment near the N-terminus is a signal peptide. Its cleavage generates an N-terminal extracellular domain with five potential N-linked glycosylation sites. The protein has the characteristics of a G protein coupled receptor. The C-terminal domain of SMO is unusually large (481 amino acids). It includes five potential phosphorylation sites for PKA that together with the PKA site of the second intracellular loop, might serve to desensitize SMO by uncoupling SMO from the G alpha protein subunit (Alcedo, 1996 and van den Heuval, 1996).
date revised: 10 August 2003
Home page: The Interactive Fly © 1995, 1996 Thomas B. Brody, Ph.D.
The Interactive Fly resides on the
Society for Developmental Biology's Web server.